These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 608549)
1. Prospects for immunotherapy. Woodruff MF Dev Biol Stand; 1977 Apr 13-15; 38():573-80. PubMed ID: 608549 [TBL] [Abstract][Full Text] [Related]
2. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer? Zöller M; Matzku S Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935 [TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of solid tumors. Current status and prospects]. Valente MG; Tagliaferri F; Stipa F; Arklins K; Cesareo S; Sirovich I Recenti Prog Med; 1996; 87(7-8):358-61. PubMed ID: 8975338 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
6. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
7. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review). Bubeník J; Símová J Oncol Rep; 2005 Nov; 14(5):1377-80. PubMed ID: 16211312 [TBL] [Abstract][Full Text] [Related]
14. Problems and prospects of new immunotherapeutic approaches. Fridman WH; Mathiot C; Michon J; Teillaud JL; Dorval T; Zucker JM; Pouillart P Cancer Detect Prev; 1990; 14(6):657-60. PubMed ID: 2257565 [TBL] [Abstract][Full Text] [Related]
15. Surgeons: A Future Role in Clinical Trials? Rusch VW Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050 [TBL] [Abstract][Full Text] [Related]
16. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy. Schultze JL; Grabbe S; von Bergwelt-Baildon MS Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836 [TBL] [Abstract][Full Text] [Related]
17. Immune monitoring of cancer patients undergoing experimental immunotherapy. Shankar G; Salgaller ML Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653 [TBL] [Abstract][Full Text] [Related]
18. Prospects for the therapeutic use of human monoclonal antibodies. Larrick JW; Bourla JM J Biol Response Mod; 1986 Oct; 5(5):379-93. PubMed ID: 3534144 [TBL] [Abstract][Full Text] [Related]